Nicorette Invisi Transdermal Patch Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Nicotine

Indications/Uses

Tobacco dependence by relieving nicotine craving & w/drawal symptoms facilitating smoking cessation in smokers motivated to quit.

Click to view Nicorette Invisi Transdermal Patch detailed prescribing information

Dosage/Direction for Use

Heavy smoker (≥15 cigarettes in 24-hr period) One 25-mg patch/16 hr daily for 1st 8 wk, then one 15-mg patch/16 hr daily for the next 2 wk & one 10-mg patch/16 hr daily for the final 2 wk. Light smoker (<15 cigarettes in 24-hr period) One 15-mg patch/16 hr daily for 1st 8 wk then one 10-mg patch/16 hr daily for the final 4 wk.

Click to view Nicorette Invisi Transdermal Patch detailed prescribing information

Overdosage

View Nicorette Invisi Transdermal Patch overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Nicorette Invisi Transdermal Patch detailed prescribing information

Special Precautions

Discontinue use if any symptoms of nicotine excess occur. Recent stroke, MI, unstable angina, cardiac arrhythmia, CABG & angioplasty or uncontrolled HTN; diabetes; overactive thyroid gland; phaeochromocytoma; stomach ulcer, oesophagitis; history of epilepsy & seizures. Remove patch prior to MRI procedures. Not recommended to use >6 mth. Moderate to severe liver &/or severe kidney disease. Pregnancy. Avoid use during lactation. Not to be used in childn & adolescents <18 yr.

Click to view Nicorette Invisi Transdermal Patch detailed prescribing information

Use In Pregnancy & Lactation

Click to view Nicorette Invisi Transdermal Patch detailed prescribing information

Adverse Reactions

Rash, hives. Dizziness, headache, irritability or aggression, feeling low, anxiety restlessness, poor concentration, increased appetite or wt gain, urge to smoke (craving), sleeplessness or sleep disturbance, low heart rate.

Drug Interactions

Concomitant use w/ drugs containing theophylline, tacrine, clozapine, ropinirole, imipramine, olanzapine, clomipramine, fluvoxamine, flecainide, pentazocine.

Click to view Nicorette Invisi Transdermal Patch detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Nicorette Invisi Transdermal Patch detailed prescribing information

Storage

View Nicorette Invisi Transdermal Patch storage conditions for details to ensure optimal shelf-life.

Description

View Nicorette Invisi Transdermal Patch description for details of the chemical structure and excipients (inactive components).

Action

View Nicorette Invisi Transdermal Patch mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Drugs Used in Substance Dependence

ATC Classification

N07BA01 - nicotine ; Belongs to the class of drugs used in the management of nicotine dependence.

Regulatory Classification

Presentation/Packing

Form

Nicorette Invisi Transdermal Patch 10 mg

Packing/Price

7 × 1's

Form

Nicorette Invisi Transdermal Patch 15 mg

Packing/Price

7 × 1's

Form

Nicorette Invisi Transdermal Patch 25 mg

Packing/Price

7 × 1's

Nicorette Invisi Transdermal Patch

nicotine

Manufacturer:

JNTL

Distributor:

Zuellig Pharma